Varex Imaging Corporation Set to Engage with Investors Soon
Varex Imaging Corporation Set to Engage with Investors
SALT LAKE CITY -- Varex Imaging Corporation (Nasdaq: VREX) is excited to announce that its management team is scheduled to take part in several important investor conferences. This provides an excellent opportunity for the company to connect with investors and showcase its industry innovations and growth strategies.
Details of Upcoming Investor Conferences
Management's participation includes the following notable events:
BTIG MedTech Conference
The first event is the BTIG's 12th Annual MedTech, Digital Health, LS&D Tools Conference. This gathering will take place in a stunning location, with one-on-one meetings scheduled. Attendees can look forward to insightful discussions about the latest technologies and market trends on February 12, 2025.
B. Riley Securities Precision Oncology & Radiopharma Conference
Later in the month, Varex will be at the B. Riley Securities Precision Oncology & Radiopharma Conference on February 28, 2025, in New York City. This conference aims to explore groundbreaking advancements in precision medicine and the relevance of imaging technology in oncology.
About Varex Imaging Corporation
Founded with a commitment to innovation, Varex Imaging Corporation stands as a leading designer and manufacturer of X-ray imaging components. Its extensive range of products includes advanced X-ray tubes, digital detectors, and sophisticated image processing solutions essential for modern X-ray imaging systems. With over 70 years of innovation, Varex provides tools critical for medical, industrial, and security imaging applications. The company collaborates with global OEM manufacturers, integrating its imaging solutions into diagnostic and preventative systems used worldwide.
Global Presence and Workforce
The company is headquartered in Salt Lake City, employing around 2,300 professionals spread across North America, Europe, and Asia. This diverse workforce is dedicated to advancing the field of imaging technology, ensuring that Varex remains at the forefront of the industry.
Frequently Asked Questions
1. What conferences is Varex Imaging Corporation attending?
Varex Imaging Corporation will participate in the BTIG MedTech Conference and the B. Riley Securities Precision Oncology & Radiopharma Conference.
2. When are these conferences scheduled?
The BTIG MedTech Conference is on February 12, 2025, and the B. Riley Conference is on February 28, 2025.
3. What does Varex specialize in?
Varex specializes in X-ray imaging components, including tubes and digital detectors, crucial for various imaging systems.
4. How large is Varex Imaging Corporation?
Varex employs approximately 2,300 people globally, with operations in North America, Europe, and Asia.
5. How long has Varex been in the industry?
Varex has been innovating in the imaging technology field for over 70 years, establishing a robust legacy of development and advancement.
About The Author
Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.